2 completed, 1 terminated. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
Follow Colchicine: new trials by email Literature Review of Colchicine trials Research Report on Colchicine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction Colchicine - HFpEF - Heart Failure With Preserved Ejection Fraction, Colchicine | Phase 1 / Phase 2 | Completed | I.M. Sechenov First Moscow State Medical University | 42 | 2022-12-15 | 2026-04-23 |
| Colchicine in HFpEF Colchicine, Placebo - Heart Failure, Inflammation | Phase 2 | Terminated | Montreal Heart Institute | 14 | 2022-06-17 | 2023-04-26 |
| Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease Colchicine 0.5 mg, Colchicine 0.25 mg, Placebo - Colchicine, Diabetes Mellitus, Type 2 | Phase 2 | Completed | University of the Ryukyus | 54 | 2017-06-15 | 2022-05-12 |
Inflammation (2) · Coronary Artery Disease (1) · Diabetes Mellitus, Type 2 (1) · Diarrhea (1) · Heart Failure (1)
Cardiovascular Diseases (2) · Heart Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Arterial Occlusive Diseases (1) · Arteriosclerosis (1) · Coronary Disease (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Myocardial Ischemia (1) · Nutritional and Metabolic Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Digestive (1)
Colchicine (3)
I.M. Sechenov First Moscow State Medical University (1) · Montreal Heart Institute (1) · University of the Ryukyus (1)
Canada (1) · Japan (1) · Russia (1)
Anastasia Shchendrygina (1) · Nadia Bouabdallaoui, MD (1) · Shinichiro Ueda, PhD (1)